解决COVID-19的影响。确保进步。
A new reality for clinical trials
In a few short months, COVID-19 has transformed how healthcare works. It has diverted expertise and resources and changed the way patients are diagnosed and treated. Disrupted the development and delivery of medicines.
The result is a new environment for clinical trials. And while some issues may resolve in the short term, others may signal a more permanent shift.
That is why IQVIA deployed a task force dedicated to ensuring patient safety and trial continuity. We are here to help customers navigate today’s challenges and ensure your business, and your commitment to patients, remains strong.
标准化风险评估。自定义解决方案。
IQVIA的研发解决方案COVID-19工作组迅速动员起来，为机上和新试验开发了标准化的风险评估方法。
Customers receive custom reports detailing risks and mitigation strategies to support trial continuity and patient safety, and to help you continue to drive healthcare forward - today.
Strategic regulatory support
机上研究可能需要修改协议，以确保患者就诊并继续剂量；IQVIA的监管专家提供了指导，以支持这种试验的灵活性。
无论是家庭访问的修订，对IRB提交的支持还是对协议修改的批准或其他全球监管文件，我们的专家都可以提供帮助。
Supported patients. Trial continuity.
远程医疗赋予了能力。
Travel restrictions and limitations on face-to-face interactions may necessitate moving to a fully remote or hybrid decentralized trial model to help ensure continuity and compliance. IQVIA Study Hub is a cloud platform that allows patients and study teams to securely connect in a televisit. It also gives patients the ability to upload medical history or patient reported outcomes easily from their tablet, smartphone or web browser.
Patients need to stay home. Meet them there.
一些试验患者可能需要家庭护理。通过我们的合作伙伴网络，IQVIA提供了训练有素的护士和静脉混血儿的家庭支持，有助于降低医疗保健环境中感染的风险。必威手机APP
We further support in-home visits by shipping lab supplies and investigational product to the patient or the home health nursing partner.
直接向患者带来试验，以改善访问和参与度，提高质量并缩短时间表。
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
通过专家见解来浏览复杂的监管要求，并为您的监管事务策略带来透明度，效率和可预测性。betway必威怎么提款
所有COVID-19试验的在线筛选器和试用匹配工具
集中监控安全性和连续性
无论是通过电视，现场访问还是家庭护理，IQVIA都可以通过远程监控有效地监视现场和患者。通过利用集中监测，我们正在将传统监测的临床试验转移到基于风险的监测解决方案，从而为COVID-19撞击提供了快速缓解策略。这种方法包括
- 研究风险评估确定最佳远程监控策略以支持患者的安全和数据质量
- 我们的全球规模rapidly deploy risk-based analytics and remote mitigation steps
1,000+
virtual meetings facilitated in the past two years by IQVIA Site Training team
保持时间表
As more interactions are moving to virtual settings, it is critical to ensure timelines and productivity are maintained.
IQVIA经验丰富的促进者是您学习团队的无缝扩展，提供内容创建和交付以及物流和技术管理。
Supported by professional trainers, behavioral strategists, medical writers and technical producers, our team has facilitated more than 1,000 virtual meetings in the past two years earning a >90% satisfaction rating.
管理生物样品的连续性
IQVIA works closely withQ2解决方案, a joint venture between IQVIA and Quest Diagnostics.
Q2解决方案已完全运行，并正在与多个客户合作，以加快潜在的Covid-19疫苗和治疗方法的启动。我们也有partnered with the University of Texas Medical Branchto develop an assay to help determine the effectiveness of vaccine candidates in protecting a person from COVID-19, and are collaborating with government and private healthcare companies in using our resources to support community testing efforts.
使用一流的数据源和正确的站点利用众多传染病和疫苗专家。
We are committed to reducing the impact of COVID-19. Learn more about how we are helping.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.